A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants
NCT07730554
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Forehead Lines
Interventions
DRUG:
AGN-151586
Sponsor
AbbVie